Possibly this one? NIH "State of the Science" conference -
https://www.cfids-me.org/marys/nihprobs.html
nice find!
Hah, sidekick Sharpe was there as well:
"
If anyone had doubts as to the insularity of the NIH community, they were dispelled when the NIH secretly put together a "State of the Science" conference that was to help inform NIH decision-makers about the current status of research on CFS. In planning the conference,
they invited only four "experts: Stephen Straus (of NIH), Mark Demitrack (of Eli Lilly), Simon Wesseley (from the UK), and Michael Sharpe (also from the UK). All are strongly biased in favor of the beliefs that CFS/M.E. is caused by "stress" and is a form of psychiatric illness they call "functional somatization;" Straus and Demitrack recommend SSRI's (Prozac) and "stress reduction," Wessely recommends traditional psychiatric talking therapy, and Sharpe recommends "cognitive behavior therapy;" all four recommend exercise. These are the
only therapies any of the four acknowledges as valid.
After protest by the Chronic Fatigue Syndrome Coordinating Committee (CFSCC), an advisory group chartered by Congress in 1997 to coordinate activities within the different agencies of the U.S. Department of Health and Human Services (DHHS) - including NIH - the name was changed to an "Internal NIAID Consultation." Dr. Nancy Klimas was added to the list of invited participants eight days before the conference was to be held, but she was not permitted to give a presentation (although unlike other observers from the CFSCC, she was permitted to speak up). It goes without saying that she was not a participant in the planning of the meeting.
Our concern did not stem from a particular dislike of any of the four participants (although members of the NIH communicated afterwards that they thought personal taste was the reason we objected to the choices). One of the four would have been fine - after all, their perspective need not be excluded. However, by choosing
only these four, the The narrow perspective voiced by Straus, Demitrack, Wessely and Sharpe can only harden the existing biased picture of CFS/M.E within the NIH. This meeting is not insignificant; NIH has stated that the intention is to "teach" NIH decision-makers "about CFS." The meeting will have a strong influence on future NIH policy towards the disease, research funding, and the plight of patients. As Jon Sterling (former president of the NJ CFS Assoc. and current patient representative on the CFSCC) stated in a formal letter of protest,
"the view of these 'experts' would take us back to 1991 in terms of scientific progress in CFS research."
and so it came to pass......